Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZARGA Replacement Therapy in Glaucoma
NCT01514734Phase 4Terminated
- Sponsor
- Alcon Inc.
- Start
- Mar 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brinzolamide in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Mar 2012; status: terminated.
02
Drugs
brinzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01514734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01514734.